Concepedia

Publication | Closed Access

Rapamycin Inhibits the Growth and Metastatic Progression of Non-Small Cell Lung Cancer

106

Citations

26

References

2004

Year

Abstract

The immunosuppressive macrolide rapamycin but not cyclosporine prevents the growth and metastatic progression of NSCLC. A rapamycin-based immunosuppressive regimen may be of value in recipients of allografts.

References

YearCitations

Page 1